Wall Street Maintains Positive Bias on MAP Pharmaceuticals (MAPP) Despite Levadex Setback
Go back to Wall Street Maintains Positive Bias on MAP Pharmaceuticals (MAPP) Despite Levadex Setback| MAP Pharmaceuticals, Inc. (NYSE: MAPP) | Delayed: 28.29 -0.01 (0.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.30 | 52 Week High | $25.03 | |||
| Open | $28.31 | 52 Week Low | $11.11 | |||
| Day High | $28.33 | P/E | N/A | |||
| Day Low | $28.29 | EPS | $-3.11 | |||
| Volume | 1,406 | |||||
